natgillin/translations-raw huggingface dataset:
Reproduction is authorised provided the source is acknowledged. neurotransmitters are involved in the control of emotions, dextromethorphan helps to normalise its activity in the brain, reducing the symptoms of PBA.
Reproduction is authorised provided the source is acknowledged. tieto neurotransmitery sa podieľajú na riadení emócií, dextrometorfán pomáha normalizovať ich pôsobenie v mozgu, čím znižuje symptómy PBA.
Reproduction is authorised provided the source is acknowledged. obese patients compared the effects of Xenical and placebo over four years, in combination with diet and exercise.
Reproduction is authorised provided the source is acknowledged. počas štvorročného obdobia, v kombinácii s diétou a telesným cvičením.
Reproduction is authorised provided the source is acknowledged. on the outer membrane of the virus) of a virus called A(H1N1)v 2009.
Reproduction is authorised provided the source is acknowledged. antigénov (proteínov z vonkajšej membrány vírusu) vírusu nazývaného A (H1N1)v 2009.
Reproduction is authorised provided the source is acknowledged. pandemic happens when a new strain of flu virus appears that can spread easily from person to person because people have no immunity (protection) against it.
Chrípková pandémia nastane vtedy, keď sa objaví nový kmeň chrípkového vírusu, ktorý sa môže ľahko šíriť z človeka na človeka, pretože ľudia proti nemu nemajú vytvorenú imunitu (ochranu).
Reproduction is authorised provided the source is acknowledged. patient should use is based on the amount of levodopa they need to control their symptoms.
Reproduction is authorised provided the source is acknowledged. symptómov.
Reproduction is authorised provided the source is acknowledged. patients who have a condition known as ‘acute coronary syndrome’, when it should be given with aspirin (another medicine that prevents blood clots), including patients who have had a stent inserted (a short tube placed in an artery to prevent it closing up).
Reproduction is authorised provided the source is acknowledged. pacientom so stavom, ktorý je známy ako akútny koronárny syndróm, pri ktorom sa má liek podávať spolu s aspirínom (ďalší liek, ktorý bráni tvorbe krvných zrazenín) vrátane pacientov, ktorí majú zavedený stent (krátka rúrka umiestnená v tepne, ktorá bráni jej uzavretiu).
Reproduction is authorised provided the source is acknowledged. patients who have a condition known as ‘acute coronary syndrome’, when it should be given with aspirin (another medicine that prevents blood clots), including patients who have had a stent inserted (a short tube placed in an artery to prevent it closing up).
Reproduction is authorised provided the source is acknowledged. pacientov s ochorením známym ako tzv. akútny koronárny syndróm, keď by sa liek mal podávať s aspirínom (ďalší liek na prevenciu krvných zrazenín) vrátane pacientov, ktorým bol zavedený stent (krátka trubička umiestnená v tepne, aby sa zabránilo jej uzavretiu).
Reproduction is authorised provided the source is acknowledged. patients who have a condition known as ‘acute coronary syndrome’, when it should be given with aspirin (another medicine that prevents blood clots), including patients who have had a stent inserted (a short tube placed in an artery to prevent it closing up).
Reproduction is authorised provided the source is acknowledged. pacientov s ochorením známym ako tzv. akútny koronárny syndróm, keď by sa liek mal podávať s aspirínom (ďalším liekom na prevenciu krvných zrazenín) vrátane pacientov, ktorým bol zavedený stent (krátka trubička umiestnená v tepne, aby sa zabránilo jej uzavretiu).
Reproduction is authorised provided the source is acknowledged. patients whose bodies may break Onsenal down slowly.
Reproduction is authorised provided the source is acknowledged. ktorých telo môže štiepiť liek Onsenal pomaly, môže byť potrebná nižšia počiatočná dávka.
Reproduction is authorised provided the source is acknowledged. patient’s response (10 to 14 days are usually needed in nosocomial pneumonia).
Reproduction is authorised provided the source is acknowledged. a závažnosti infekcie a odpovede pacienta (v prípade nozokomiálnej pneumónie je zvyčajne potrebných 10 až 14 dní).
Reproduction is authorised provided the source is acknowledged. people have no immunity (protection) against it.
Reproduction is authorised provided the source is acknowledged. vírusu, ktorý sa môže ľahko šíriť z človeka na človeka, pretože ľudia proti nemu nemajú vytvorenú imunitu (ochranu).
Reproduction is authorised provided the source is acknowledged. permanently stopped.
Reproduction is authorised provided the source is acknowledged. alebo dočasne liečbu zastaviť.
Reproduction is authorised provided the source is acknowledged. pressure is not reached, the dose can be increased to 80 mg, or another medicine for hypertension can be added, such as hydrochlorothiazide.
Ak sa nedosiahne želaný krvný tlak, dávka sa môže zvýšiť na 80 mg, alebo sa môže pridať ďalší liek na vysoký tlak, napríklad hydrochlorotiazid.
Reproduction is authorised provided the source is acknowledged. primary generalised tonic-clonic seizures (major fits, including loss of consciousness) in patients from 12 years of age with idiopathic generalised epilepsy (the type of epilepsy that is thought to be inherited).
Reproduction is authorised provided the source is acknowledged. primárne generalizovaných tonicko–klonických záchvatov (závažnejších záchvatov vrátane straty vedomia) u pacientov vo veku od 12 rokov s idiopatickou generalizovanou epilepsiou (druhom epilepsie, u ktorej sa predpokladá, že dedičná).
Reproduction is authorised provided the source is acknowledged. primary generalised tonic-clonic seizures (major fits, including loss of consciousness) in patients from 12 years of age with idiopathic generalised epilepsy (the type of epilepsy that is thought to have a genetic cause).
Reproduction is authorised provided the source is acknowledged. primárne generalizovaných tonicko-klonických záchvatov (závažné záchvaty vrátane straty vedomia) u pacientov vo veku od 12 rokov s generalizovanou idiopatickou epilepsiou (typ epilepsie, u ktorej sa predpokladá genetické podmienenie).
Reproduction is authorised provided the source is acknowledged. primary generalised tonic-clonic seizures (major fits, including loss of consciousness) in patients from 12 years of age with idiopathic generalised epilepsy (the type of epilepsy that is thought to have a genetic cause).
Reproduction is authorised provided the source is acknowledged. primárne generalizovaných tonicko–klonických záchvatov (závažnejších záchvatov vrátane straty vedomia) u pacientov vo veku od 12 rokov s idiopatickou generalizovanou epilepsiou (druh epilepsie, u ktorej sa predpokladá genetické podmienenie).
Reproduction is authorised provided the source is acknowledged. prostaglandins are substances that trigger inflammation, pain, exudation and fever, meloxicam reduces those responses.
Reproduction is authorised provided the source is acknowledged. prostaglandíny sú látky, ktoré vyvolávajú zápal, bolesť, potenie a horúčku, meloxikam zmierňuje tieto reakcie.
Reproduction is authorised provided the source is acknowledged. protein called ‘SMO’, which is involved in activating the Hedgehog signalling pathway.
Reproduction is authorised provided the source is acknowledged. určitých bunkových procesoch dospelých.
Reproduction is authorised provided the source is acknowledged. reached, the dose can be increased to 80 mg, or another medicine for hypertension can be added, such as hydrochlorothiazide.
Reproduction is authorised provided the source is acknowledged. želaný krvný tlak, dávka sa môže zvýšiť na 80 mg, alebo sa môže pridať ďalší liek na vysoký tlak, napríklad hydrochlorotiazid.
Reproduction is authorised provided the source is acknowledged. recommended one month after the initial treatment.
Reproduction is authorised provided the source is acknowledged. odporúča ďalšia liečba jeden mesiac po pôvodnej liečbe.
Reproduction is authorised provided the source is acknowledged. reduces the numbers of eosinophils.
Reproduction is authorised provided the source is acknowledged. eozinofilov.
Reproduction is authorised provided the source is acknowledged. released more slowly from the capsule than it is in Prograf/Prograft.
Rozmnožovanie je povolené len so súhlasom agentúry. pomalšie, ako to bolo pri Prografe/Prografte.
Reproduction is authorised provided the source is acknowledged. replacement.
Reproduction is authorised provided the source is acknowledged. zákroku na nahradenie bedrového kĺbu alebo 10 až 14 dní po chirurgickom zákroku na nahradenie kolenného kĺbu.
Reproduction is authorised provided the source is acknowledged. replicate and slows down the spread of infection.
Reproduction is authorised provided the source is acknowledged. vírusu replikovať sa a spomaľuje šírenie infekcie.
Reproduction is authorised provided the source is acknowledged. rumen resulting in an increase of the bacteria that produce propionate, a substance used to make glucose.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. same time as the first infusion.
Reproduction is authorised provided the source is acknowledged. prvá infúzia.
Reproduction is authorised provided the source is acknowledged. same time), two doses may be given two months apart, from the age of two months, followed by a booster at least six months later.
Reproduction is authorised provided the source is acknowledged. približne v rovnakom čase), môžu sa od veku dvoch mesiacov podať dve dávky s dvojmesačným časovým odstupom a potom posilňovacia dávka s aspoň šesťmesačným časovým odstupom.
Reproduction is authorised provided the source is acknowledged. same way as human factor VIII.
Reproduction is authorised provided the source is acknowledged. ľudský faktor VIII.
Reproduction is authorised provided the source is acknowledged. severe active axial spondyloarthritis without evidence on the X-ray of ankylosing spondylitis but with objective signs of inflammation who have not responded adequately or are intolerant to NSAIDs. psoriatic arthritis (a disease causing red, scaly patches on the skin and inflammation of the joints).
Reproduction is authorised provided the source is acknowledged. psoriatická artritída (choroba spôsobujúca červené, šupinaté škvrny na pokožke a zápaly kĺbov).
Reproduction is authorised provided the source is acknowledged. severity of the condition; the recommended starting dose is 1 to 2 mg per kg of body weight daily, given by injection under the skin.
Reproduction is authorised provided the source is acknowledged. hmotnosti denne vo forme injekcie pod kožu.
Reproduction is authorised provided the source is acknowledged. since the 1950s.
Reproduction is authorised provided the source is acknowledged. minulého storočia.
Reproduction is authorised provided the source is acknowledged. six hours or extend the monitoring period if needed.
Reproduction is authorised provided the source is acknowledged. sledovania predĺžiť.
Reproduction is authorised provided the source is acknowledged. stimulates the growth and activity of eosinophils.
Reproduction is authorised provided the source is acknowledged. aktivitu eozinofilov.
Reproduction is authorised provided the source is acknowledged. strength that continues to provide the same doses.
Reproduction is authorised provided the source is acknowledged. rovnaké dávky týchto účinných látok.
Reproduction is authorised provided the source is acknowledged. substance which increases electrical activity in the brain.
Reproduction is authorised provided the source is acknowledged. v mozgu.
Reproduction is authorised provided the source is acknowledged. sure that blood phenylalanine levels and nutritional balance are controlled.
Reproduction is authorised provided the source is acknowledged. kontrola hladiny fenylalanínu v krvi a výživovej rovnováhy.
Reproduction is authorised provided the source is acknowledged. susoctocog alfa, works in the body in the same way as human factor VIII, but has a slightly different shape.
Reproduction is authorised provided the source is acknowledged. látka lieku Obizur, susoktokog alfa, účinkuje v tele rovnakým spôsobom ako ľudský faktor VIII, ale má trochu odlišný tvar.
Reproduction is authorised provided the source is acknowledged. system.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. taking Brilique should also be taking aspirin as directed by their doctor.
Reproduction is authorised provided the source is acknowledged. môže odporučiť, aby zo zdravotných dôvodov aspirín neužívali.
Reproduction is authorised provided the source is acknowledged. the day, which should be at least 30 minutes after taking the tablet.
Reproduction is authorised provided the source is acknowledged. jedlom, čo by malo byť najmenej 30 minút po užití tablety.
Reproduction is authorised provided the source is acknowledged. the maximum number is 4.
Odporúčajú sa tri implantáty ročne, pričom maximálny počet je 4.
Reproduction is authorised provided the source is acknowledged. the number of applications can be increased to three or four times a day.
Reproduction is authorised provided the source is acknowledged. štyrikrát denne v závislosti od reakcie každej lézie na liečbu.
Reproduction is authorised provided the source is acknowledged. the patient responds to treatment and, in the case of children, on the body surface area.
Reproduction is authorised provided the source is acknowledged. liečbu a v prípade detí aj od plochy povrchu tela.
Reproduction is authorised provided the source is acknowledged. the second dose given two months after the first and the third given four months after the second.
Reproduction is authorised provided the source is acknowledged. po prvej dávke, vždy sa má podať aj tretia dávka.
Reproduction is authorised provided the source is acknowledged. the second doses, and at least three months between the second and the third, and all doses should be given within a year.
Reproduction is authorised provided the source is acknowledged. druhá dávka má podať dva mesiace po prvej dávke a tretia dávka sa podáva štyri mesiace po druhej dávke.
Reproduction is authorised provided the source is acknowledged. the solution should be given by infusion (drip) into a vein over 15 minutes at a dose of 20 micrograms per kilogram body weight.
U detí sa má roztok podávať vo forme infúzie (kvapkaním) do žily v trvaní 15 minút v dávke 20 mikrogramov na kilogram telesnej hmotnosti.
Reproduction is authorised provided the source is acknowledged. the type and stage of the disease being treated.
Reproduction is authorised provided the source is acknowledged. ktorou sa liečba začína, závisí od typu a štádia liečeného ochorenia.
Reproduction is authorised provided the source is acknowledged. the vaccine’s effect.
Reproduction is authorised provided the source is acknowledged. aby sa zachoval účinok očkovacej látky.
Reproduction is authorised provided the source is acknowledged. they should not be sucked, chewed or swallowed whole.
Reproduction is authorised provided the source is acknowledged. žuvať ani prehĺtať v celku.
Reproduction is authorised provided the source is acknowledged. tissues where the cancer has spread, and the alpha particles destroy surrounding cancer cells and help to control the associated symptoms.
Reproduction is authorised provided the source is acknowledged. akumuluje v kostnom tkanive, do ktorého sa karcinóm rozšíril a častice alfa zničia okolité rakovinové bunky, čo pomáha kontrolovať súvisiace príznaky.
Reproduction is authorised provided the source is acknowledged. to reduce the need for blood transfusions in adults with moderate anaemia who are about to undergo major orthopaedic (bone) surgery, such as hip surgery.
Reproduction is authorised provided the source is acknowledged. na zníženie potreby krvných transfúzií u dospelých so stredne závažnou anémiou, ktorí majú podstúpiť rozsiahlu ortopedickú operáciu (operáciu kostí), ako napríklad operáciu bedrového kĺbu.
Reproduction is authorised provided the source is acknowledged. to treat persistent neutropenia in patients with advanced human immunodeficiency virus (HIV) infection, to reduce the risk of bacterial infections when other treatments are not appropriate.
Reproduction is authorised provided the source is acknowledged. na liečbu perzistentnej neutropénie u pacientov s pokročilou infekciou vírusom ľudskej imunodeficiencie (HIV) s cieľom znížiť riziko bakteriálnych infekcií, keď iné možnosti liečby nie sú vhodné.
Reproduction is authorised provided the source is acknowledged. tolerates the treatment.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. toxin, the immune system will be able to make antibodies against it more quickly.
Reproduction is authorised provided the source is acknowledged. toxín, imunitný systém bude schopný proti nemu rýchlejšie vytvoriť protilátky.
Reproduction is authorised provided the source is acknowledged. treatment for as long as the doctor believes the patient is benefiting from it.
Reproduction is authorised provided the source is acknowledged. týždňovom cykle bez liečby tak dlho, kým sa lekár domnieva, že liečba pacientovi prospieva.
Reproduction is authorised provided the source is acknowledged. treatment of both asthma and COPD, while Revinty Ellipta 184/22 microgram (184 micrograms of fluticasone furoate and 22 micrograms of vilanterol) can only be used for the treatment of asthma.
Reproduction is authorised provided the source is acknowledged. sa môže používať na liečbu astmy aj choroby CHOCHP, zatiaľ čo liek Revinty Ellipta 184/22 mikrogramov (184 mikrogramov flutikazónfuroátu a 22 mikrogramov vilanterolu) sa môže používať len na liečbu astmy.
Reproduction is authorised provided the source is acknowledged. treatment with Axura should be reassessed on a regular basis.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. treatment with Ebixa should be reassessed on a regular basis.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. vaccinated dogs since the vaccine does not prevent Leishmania infection.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. virus.
Reproduction is authorised provided the source is acknowledged. vírusu chrípky.
Reproduction is authorised provided the source is acknowledged. week break without treatment and then a further two weeks of treatment.
Reproduction is authorised provided the source is acknowledged. a potom ďalšia dvojtýždňová liečba.
Reproduction is authorised provided the source is acknowledged. weekly injections followed by monthly maintenance injections.
Reproduction is authorised provided the source is acknowledged. podáva formou injekcie pod kožu ako štyri injekcie týždenne a potom nasledujú udržiavacie injekcie podávané raz mesačne.
Reproduction is authorised provided the source is acknowledged. weight, and the infusion should last around one hour.
Reproduction is authorised provided the source is acknowledged. hmotnosti a infúzia má trvať asi jednu hodinu.
Reproduction is authorised provided the source is acknowledged. with a type of diabetes medicine called a sulphonylurea or with insulin, the dose of the sulphonylurea or insulin may need to be lowered to avoid hypoglycaemia (low blood sugar levels).
Keď sa liek používa v kombinácii s typom lieku proti cukrovke, ktorý sa nazýva sulfonylmočovina alebo s inzulínom, dávka sulfonylmočoviny alebo inzulínu sa možno bude musieť znížiť, aby sa zabránilo hypoglykémii (nízkej hladine cukru v krvi).
Reproduction is authorised provided the source is acknowledged. work in similar ways to reduce blood pressure by allowing the blood vessels to relax.
Reproduction is authorised provided the source is acknowledged. ciev.
Reproduction studies and other data in animals do not indicate a concern regarding fertility in either males or females (see section 5.3).
Reprodukčné štúdie a iné údaje u zvierat nenaznačujú problémy týkajúce sa fertility ani u samcov, ani u samíc (pozri časť 5.3).
Reproduction studies and other data in animals do not indicate a concern regarding fertility in either males or females.
Reprodukčné štúdie a iné údaje u zvierat nenaznačujú problémy týkajúce sa fertility ani u samcov, ani u samíc.
Reproduction studies by oral administration of buprenorphine: naloxone (ratio 1:1) indicated that embryolethality occurred in rats in the presence of maternal toxicity at all doses.
Reprodukčné štúdie perorálnym podávaním buprenorfínu a naloxónu (v pomere 1:1) ukázali, že embryonálna letalita sa objavila u potkanov v prítomnosti maternálnej toxicity pri všetkých dávkach.
Reproduction studies carried out with ganirelix at doses of 0.1 to 10 g/kg/day subcutaneously in the rat and 0.1 to 50 g/kg/day subcutaneously in the rabbit showed increased litter resorption in the highest dose groups.
Reprodukčné štúdie vykonané s ganirelixom v dávkach 0,1 až 10 µg/kg/deň podaných subkutánne potkanom a v dávkach 0,1 až 50 µg/kg/deň podaných subkutánne králikom, viedli v skupinách s najvyššími dávkami k zvýšeniu resorpcie embrya.
Reproduction studies have been performed in rats and rabbits at doses up to 3 mg/kg/day and have revealed no evidence of impaired fertility or harm to the embryo or foetus due to Naglazyme.
Reprodukčné štúdie vykonané na potkanoch a králikoch v dávkach do 3 mg/kg/deň neukázali žiadny dôkaz Naglazyme spôsobeného zníženia fertility alebo poškodenia embrya alebo plodu.
Reproduction studies have been performed in rats at doses up to 10 times the human dose and have revealed no evidence of impaired fertility or reproductive performance.
Reprodukčné štúdie sa vykonali u potkanov pri dávkach až do 10-násobku dávky u ľudí a nepreukázali žiadne zníženie fertility alebo reprodukčných funkcií.
Reproduction studies have shown minor embryotoxicity at doses close to maternally toxic ones (increased number of resorptions, pre-implantation and post-implantation losses).
Štúdie reprodukčnej toxicity preukázali menšiu embryotoxicitu pri dávkach blížiacim sa toxicite pre matku (zvýšený počet resorpcií, predimplantačné a postimplantačné straty).
Reproduction studies in animal species where eptifibatide shows a similar pharmacologic activity as in humans are not available.
Reprodukčné štúdie na zvieracích druhoch, u ktorých má eptifibatid podobný farmakologický účinok ako u ľudí, nie sú dostupné.
Reproduction studies in the rat and the rabbit showed no effect of agomelatine on fertility (see section 5.3).
Reprodukčné štúdie u potkana a králika preukázali, že agomelatín nemá žiadny účinok na fertilitu (pozri časť 5.3).
Reproduction studies in the rat and the rabbit showed no effect of agomelatine on fertility, embryofoetal development and pre- and post natal development.
Reprodukčné štúdie u potkana a králika preukázali, že agomelatín nemá žiadny účinok na fertilitu, embryofetálny vývoj, ani na pre-a postnatálny vývoj.
Reproduction studies of PegIntron have not been performed.
Reprodukčné štúdie sa s PegIntronom nerobili.
Reproduction studies of ViraferonPeg have not been performed.
Reprodukčné štúdie sa s ViraferonPegom nerobili.
Reproduction studies performed in rats at doses giving exposure in the same range as the human dose have revealed no evidence of impaired fertility due to ulipristal acetate in treated animals or the offspring of treated females.
Reprodukčné štúdie na potkanoch pri dávkach poskytujúcich expozíciu v rovnakom rozsahu ako ľudská dávka neodhalili žiadny dôkaz narušenej fertility spôsobený ulipristalacetátom u liečených zvierat ani u potomkov liečených samíc.
Reproduction studies showed embryo-foetotoxic effects (resorptions and post-implantation losses) in rats at the 100 mg/kg/day dose level and in rabbits receiving cysteamine 50 mg/kg/day.
Reprodukčné štúdie preukázali embryofetotoxické účinky (resorpcia a postimplantačné straty) u potkanov pri dávke 100 mg/kg/deň a u králikov, ktorým bol podávaný cysteamín v dávke 50 mg/kg/deň.